Skip to main content
PMC home page
Brain Pathology logoLink to Brain Pathology
. 2006 Apr 5;13(3):263–278. doi: 10.1111/j.1750-3639.2003.tb00027.x

Hippocampal Sclerosis Dementia with Tauopathy

Thomas G Beach 1,✉, Lucia Sue 1, Sarah Scott 1, Kathryn Layne 1, Amanda Newell 1, Douglas Walker 1, Matthew Baker 3, Naraju Sahara 3, Shu‐Hui Yen 3, Michael Hutton 3, Richard Caselli 4, Charles Adler 4, Donald Connor 2, Marwan Sabbagh 2
PMCID: PMC8095804  PMID: 12946017

Abstract

In some elderly individuals with dementia, hippocampal sclerosis (HS) is the only remarkable autopsy finding. The cause of HS in this setting is puzzling, since known causes of HS such as seizures or global hypoxic‐ischemic episodes are rarely present. We here describe a series of HS cases that have a widespread neuronal and/or glial tauopathy. Of 14 consecutive cases of HS, 12 had been clinically diagnosed with dementia and/or Alzheimer's disease (AD) while 2 were non‐demented; 7 cases had also been clinically diagnosed with parkinsonism. In addition to HS, 6 cases also met pathologic diagnostic criteria for AD. Gallyas silver staining and immunohistochemistry with the AT8 antibody revealed a glial and/or neuronal tauopathy in 12 of 14 cases, with frequent positive neurons and/or glial cells in the neocortex, basal ganglia, thalamus and/or limbic regions; in addition, 8 of the 14 cases had argyrophilic grains. Screening for known tau mutations was negative in all cases. Western blots of sarkosyl‐insoluble tau protein showed a mixture of 3‐ and 4‐repeat forms. The results suggest that most cases of HS dementia are sporadic multisystem tauopathies; we suggest the term “hippocampal sclerosis dementia with tauopathy” (HSDT) for these.

Full Text

The Full Text of this article is available as a PDF (1.2 MB).

References

  • 1. Ala TA, Beh GO, Frey WH (2000) Pure hippocampal sclerosis: a rare cause of dementia mimicking Alzheimer's disease. Neurology 54:843–848. [DOI] [PubMed] [Google Scholar]
  • 2. Arai T, Ikeda K, Akiyama H, Shikamoto Y, Tsuchiya K, Yagishita S, Beach T, Rogers J, Schwab C, McGeer PL (2001) Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol (Berl) 101:167–173. [DOI] [PubMed] [Google Scholar]
  • 3. Beach TG, Tago H, Nagai T, Kimura H, McGeer PL, McGeer EG (1987) Perfusion‐fixation of the human brain for immunohistochemistry: comparison with immersion‐fixation. J Neurosci Methods 19:183–192. [DOI] [PubMed] [Google Scholar]
  • 4. Beach TG, Walker R, McGeer EG (1989) Patterns of gliosis in Alzheimer's disease and aging cerebrum. Glia 2:420–436. [DOI] [PubMed] [Google Scholar]
  • 5. Berry RW, Quinn B, Johnson N, Cochran EJ, Ghosal N, Binder LL (2001) Pathological glial tau accumulations in neu rodegenerative disease: review and case report. Neurochem Int 39:469–479. [DOI] [PubMed] [Google Scholar]
  • 6. Bigio EH, Lipton AM, Yen SH, Hutton ML, Baker M, Nacharaju P, White CL, Davies P, Lin W, Dickson DW (2001) Frontal lobe dementia with novel tauopathy: sporadic multiple system tauopathy with dementia. J Neuropathol Exp Neurol 60:328–341. [DOI] [PubMed] [Google Scholar]
  • 7. Braak H, Braak E (1991) Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol 1:213–216. [DOI] [PubMed] [Google Scholar]
  • 8. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer‐related changes. Acta Neuropathol (Berl) 82:239–259. [DOI] [PubMed] [Google Scholar]
  • 9. Buee L, Delacourte A (1999) Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP‐17 and Pick's disease. Brain Pathol 9:681–693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Bugiani O, Murrell JR, Giaccone G, Hasegawa M, Ghigo G, Tabaton M, Morbin M, Primavera A, Carella F, Solaro C, Grisoli M, Savoiardo M, Spillantini MG, Tagliavini F, Goedert M, Ghetti B (1999) Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau. J Neuropathol Exp Neurol 58:667–677. [DOI] [PubMed] [Google Scholar]
  • 11. Cajal, SRY (1984) Neuroglia In: The Neuron and the Glial Cell. Translation of “Textura del Sistema Nervioso del Hombre y de los Vertebrados (1937)”, de la Torre J, Gibson WC (eds. and translation), PP. 263–290, Charles C. Thomas: Illinois . [Google Scholar]
  • 12. Chin SS, Goldman JE (1996) Glial inclusions in CNS degenerative diseases. J Neuropathol Exp Neurol 55:499–508. [DOI] [PubMed] [Google Scholar]
  • 13. Clark AW, White CL, Manz HJ, Parhad IM, Curry B, Whitehouse PJ, Lehmann J, Coyle JT (1986) Primary degenerative dementia without Alzheimer pathology. Can J Neurol Sci 13:462–470. [DOI] [PubMed] [Google Scholar]
  • 14. Clark LN, Poorkaj P, Wszolek Z, Geschwind DH, Nasreddine ZS, Miller B, Li D, Payami H, Awert F, Markopoulou K, Andreadis A, D'Souza I, Lee VM, Reed L, Trojanowski JQ, Zhukareva V, Bird T, Schellenberg G, Wilhelmsen KC (1998) Pathogenic implications of mutations in the tau gene in pallido‐ponto‐nigral degeneration and related neurodegenerative disorders linked to chromosome 17. Proc Natl Acad Sci U S A 95:13103–13107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Corey‐Bloom J, Sabbagh MN, Bondi MW, Hansen L, Alford MF, Masliah E, Thal LJ (1997) Hippocampal sclerosis contributes to dementia in the elderly. Neurology 48:154–160. [DOI] [PubMed] [Google Scholar]
  • 16. Delisle MB, Murrell JR, Richardson R, Trofatter JA, Rascol O, Soulages X, Mohr M, Calvas P, Ghetti B (1999) A mutation at codon 279 (N279K) in exon 10 of the Tau gene causes a tauopathy with dementia and supranuclear palsy. Acta Neuropathol ( Berl ) 98:62–77. [DOI] [PubMed] [Google Scholar]
  • 17. Dickson DW, Davies P, Bevona C, Van Hoeven KH, Factor SM, Grober E, Aronson MK, Crystal HA (1994) Hippocampal sclerosis: a common pathological feature of dementia in very old (> or = 80 years of age) humans. Acta Neuropathol ( Berl ) 88:212–221. [DOI] [PubMed] [Google Scholar]
  • 18. Ezquerra M, Pastor P, Valldeoriola F, Molinuevo JL, Blesa R, Tolosa E, Oliva R (1999) Identification of a novel polymorphism in the promoter region of the tau gene highly associated to progressive supranuclear palsy in humans. Neurosci Lett 275:183–186. [DOI] [PubMed] [Google Scholar]
  • 19. Goedert M, Spillantini MG, Crowther RA, Chen SG, Parchi P, Tabaton M, Lanska DJ, Markesbery WR, Wilhelmsen KC, Dickson DW, Petersen RB, Gambetti P (1999) Tau gene mutation in familial progressive subcortical gliosis. Nat Med 5:454–457. [DOI] [PubMed] [Google Scholar]
  • 20. Greenberg SG, Davies P, Schein JD, Binder LI (1992) Hydrofluoric acid‐treated tau PHF proteins display the same biochemical properties as normal tau. J Biol Chem 267:564–569. [PubMed] [Google Scholar]
  • 21. Hauw JJ, Daniel SE, Dickson D, Horoupian DS, Jellinger K, Lantos PL, McKee A, Tabaton M, Litvan I (1994) Preliminary NINDS neuropathologic criteria for Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy). Neurology 44:2015–2019. [DOI] [PubMed] [Google Scholar]
  • 22. Hayashi S, Toyoshima Y, Hasegawa M, Umeda Y, Wakabayashi K, Tokiguchi S, Iwatsubo T, Takahashi H (2002) Late‐onset frontotemporal dementia with a novel exon 1 (Arg5His) tau gene mutation. Ann Neurol 51:525–530. [DOI] [PubMed] [Google Scholar]
  • 23. Higgins JJ, Golbe LI, De Biase A, Jankovic J, Factor SA, Adler RL (2000) An extended 5′‐tau susceptibility haplotype in progressive supranuclear palsy. Neurology 55:1364–1367. [DOI] [PubMed] [Google Scholar]
  • 24. Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31:545–548. [PubMed] [Google Scholar]
  • 25. Houlden H, Baker M, Morris HR, MacDonald N, Pickering‐Brown S, Adamson J, Lees AJ, Rossor MN, Quinn NP, Kertesz A, Khan MN, Hardy J, Lantos PL, George‐Hyslop P, Munoz DG, Mann D, Lang AE, Bergeron C, Bigio EH, Litvan I, Bhatia KP, Dickson D, Wood NW, Hutton M (2001) Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology 56:1702–1706. [DOI] [PubMed] [Google Scholar]
  • 26. Hutton M (2001) Missense and splice site mutations in tau associated with FTDP‐17: multiple pathogenic mechanisms. Neurology 56:S21–S25. [DOI] [PubMed] [Google Scholar]
  • 27. Hutton M (2001) Missense and splice site mutations in tau associated with FTDP‐17: multiple pathogenic mechanisms. Neurology 56:S21–S25. [DOI] [PubMed] [Google Scholar]
  • 28. Hyman BT, Trojanowski JQ (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 56:1095–1097. [DOI] [PubMed] [Google Scholar]
  • 29. Iijima M, Tabira T, Poorkaj P, Schellenberg GD, Trojanowski JQ, Lee VM, Schmidt ML, Takahashi K, Nabika T, Matsumoto T, Yamashita Y, Yoshioka S, Ishino H (1999) A distinct familial presenile dementia with a novel missense mutation in the tau gene. Neuroreport 10:497–501. [DOI] [PubMed] [Google Scholar]
  • 30. Ingelson M, Fabre SF, Lilius L, Andersen C, Viitanen M, Almkvist O, Wahlund LO, Lannfelt L (2001) Increased risk for frontotemporal dementia through interaction between tau polymorphisms and apolipoprotein E epsilon4. Neuroreport 12:905–909. [DOI] [PubMed] [Google Scholar]
  • 31. Jellinger KA (1994) Hippocampal sclerosis: a common pathological feature of dementia in very old humans. Acta Neuropathol ( Berl ) 88:599. [DOI] [PubMed] [Google Scholar]
  • 32. Kalman J, Juhasz A, Majtenyi K, Rimanoczy A, Jakab K, Gardian G, Rasko I, Janka Z (2000) Apolipoprotein E polymorphism in Pick's disease and in Huntington's disease. Neurobiol Aging 21:555–558. [DOI] [PubMed] [Google Scholar]
  • 33. Komori T (1999) Tau‐positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick's disease. Brain Pathol 9:663–679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Lantos PL, Cairns NJ, Khan MN, King A, Revesz T, Janssen JC, Morris H, Rossor MN (2002) Neuropathologic variation in frontotemporal dementia due to the intronic tau 10(+16) mutation. Neurology 58:1169–1175. [DOI] [PubMed] [Google Scholar]
  • 35. Leverenz JB, Agustin CM, Tsuang D, Peskind ER, Edland SD, Nochlin D, DiGiacomo L, Bowen JD, McCormick WC, Teri L, Raskind MA, Kukull WA, Larson EB (2002) Clinical and neuropathological characteristics of hippocampal sclerosis: a community‐based study. Arch Neurol 59:1099–1106. [DOI] [PubMed] [Google Scholar]
  • 36. Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, Yen SH, Sahara N, Skipper L, Yager D, Eckman C, Hardy J, Hutton M, McGowan E (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293:1487–1491. [DOI] [PubMed] [Google Scholar]
  • 37. Lynch T, Sano M, Marder KS, Bell KL, Foster NL, Defendini RF, Sima AA, Keohane C, Nygaard TG, Fahn S (1994) Clinical characteristics of a family with chromosome 17‐linked disinhibition‐dementia‐parkinsonism‐amyotrophy complex. Neurology 44:1878–1884. [DOI] [PubMed] [Google Scholar]
  • 38. Mirra SS, Murrell JR, Gearing M, Spillantini MG, Goedert M, Crowther RA, Levey AI, Jones R, Green J, Shoffner JM, Wainer BH, Schmidt ML, Trojanowski JQ, Ghetti B (1999) Tau pathology in a family with dementia and a P301L mutation in tau. J Neuropathol Exp Neurol 58:335–345. [DOI] [PubMed] [Google Scholar]
  • 39. Morris HR, Schrag A, Nath U, Burn D, Quinn NP, Daniel S, Wood NW, Lees AJ (2001) Effect of ApoE and tau on age of onset of progressive supranuclear palsy and multiple system atrophy. Neurosci Lett 312:118–120. [DOI] [PubMed] [Google Scholar]
  • 40. Nasreddine ZS, Loginov M, Clark LN, Lamarche J, Miller BL, Lamontagne A, Zhukareva V, Lee VM, Wilhelmsen KC, Geschwind DH (1999) From genotype to phenotype: a clinical pathological, and biochemical investigation of frontotemporal dementia and parkinsonism (FTDP‐17) caused by the P301Ltau mutation. Ann Neurol 45:704–715. [DOI] [PubMed] [Google Scholar]
  • 41. Rasmusson DX, Brandt J, Steele C, Hedreen JC, Troncoso JC, Folstein MF (1996) Accuracy of clinical diagnosis of Alzheimer disease and clinical features of patients with non‐Alzheimer disease neuropathology. Alzheimer Dis Assoc Disord 10:180–188. [DOI] [PubMed] [Google Scholar]
  • 42. Reed LA, Schmidt ML, Wszolek ZK, Balin BJ, Soontornniyomkij V, Lee VM, Trojanowski JQ, Schelper RL (1998) The neuropathology of a chromosome 17‐linked autosomal dominant parkinsonism and dementia (“pallidoponto‐nigral degeneration”). J Neuropathol Exp Neurol 57:588–601. [DOI] [PubMed] [Google Scholar]
  • 43. Schneider JA, Gearing M, Robbins RS, de L'Aune W, Mirra SS (1995) Apolipoprotein E genotype in diverse neurodegenerative disorders. Ann Neurol 38:131–135. [DOI] [PubMed] [Google Scholar]
  • 44. Short RA, Graff‐Radford NR, Adamson J, Baker M, Hutton M (2002) Differences in tau and apolipoprotein E polymorphism frequencies in sporadic frontotemporal lobar degeneration syndromes. Arch Neurol 59:611–615. [DOI] [PubMed] [Google Scholar]
  • 45. de Silva R, Farrer M (2002) Tau neurotoxicity without the lesions: a fly challenges a tangled web. TINS 25:327–329. [DOI] [PubMed] [Google Scholar]
  • 46. Spillantini MG, Bird TD, Ghetti B (1998) Frontotemporal dementia and Parkinsonism linked to chromosome 17: a new group of tauopathies. Brain Pathol 8:387–402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Spillantini MG, Crowther RA, Kamphorst W, Heutink P, van Swieten JC (1998) Tau pathology in two Dutch families with mutations in the microtubule‐binding region of tau. Am J Pathol 153:1359–1363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Spillantini MG, Goedert M, Crowther RA, Murrell JR, Far‐low MR, Ghetti B (1997) Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments. Proc Natl Acad Sci U S A 94:4113–4118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B (1998) Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci U S A 95:7737–7741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Sulkava R, Haltia M, Paetau A, Wikstrom J, Palo J (1983) Accuracy of clinical diagnosis in primary degenerative dementia: correlation with neuropathological findings. J Neurol Neurosurg Psychiatry 46:9–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Togo T, Sahara N, Yen SH, Cookson N, Ishizawa T, Hutton M, de Silva R, Lees A, Dickson DW (2002) Argyrophilic grain disease is a sporadic 4‐repeat tauopathy. J Neuropathol Exp Neurol 61:547–556. [DOI] [PubMed] [Google Scholar]
  • 52. Troncoso JC, Kawas CH, Chang CK, Folstein MF, Hedreen JC (1996) Lack of association of the apoE4 allele with hippocampal sclerosis dementia. Neurosci Lett 204:138–140. [DOI] [PubMed] [Google Scholar]
  • 53. Volpe BT, Petito CK (1985) Dementia with bilateral medial temporal lobe ischemia. Neurology 35:1793–1797. [DOI] [PubMed] [Google Scholar]
  • 54. Yen SH, Hutton M, DeTure M, Ko LW, Nacharaju P (1999) Fibrillogenesis of tau: insights from tau missense mutations in FTDP‐17. Brain Pathol 9:695–705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Zweig RM, Schegg KM, Peacock JH, Melarkey D (1989) A case of Alzheimer's disease and hippocampal sclerosis with normal cholinergic activity in basal forebrain, neocortex, and hippocampus. Neurology 39:288–290. [DOI] [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES